Conclusion

Philippe Ryvlin, Elson L. So

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The 20 chapters in this book offer a comprehensive review of currently available knowledge regarding epilepsy surgery in MRI-negative patients, and they suggest that we have entered a novel era for treating these patients with the most challenging epilepsies. Three primary messages in this book deserve to be emphasized. The first message is that re-evaluation of MRI data, either through optimal acquisition (more sensitive sequence, higher-field strength), post-processing tools, coregistration with other modalities (especially FDG-PET), and expert reassessment, enhances the detection of a large proportion of MRI-negative pathologies, such as focal cortical dysplasias (FCD) (Chapter 3). Up to 89% of small FCD overlooked by experts could be detected by using sophisticated post-processing methods of 3D-T1 MR images, coupled with neural networks automatic detection (Chapter 3). The second message relates to the conceptual framework of presurgical evaluation. In patients with refractory focal epilepsy whose MRI discloses a well-defined epileptogenic lesion, presurgical evaluation concentrates on refining the localization of the epileptogenic zone (EZ) to be resected. In MRI-negative patients, presurgical evaluation also needs to provide insights into the underlying pathology for several reasons: (i) the presence and type of underlying pathology have a strong impact on the chance of postsurgical seizure freedom, with optimal surgical outcome in focal cortical dysplasia (FCD) type II and end- folium sclerosis, and poorest outcome in patients with histologically normal resected tissue; (ii) the extent of the EZ varies with the underlying pathology, being usually circumscribed to a sulcus in MRI-negative FCD type II, and often much more extensive in FCD type I (Chapter 11); and (iii) interpretation of presurgical data, such as the presence or absence of a clear-cut interictal hypometabolism on FDG-PET, will differ as a function of the suspected pathology. In other words, the “what” appears as important as the “where” when contemplating surgical treatment of MRI-negative patients.

Original languageEnglish (US)
Title of host publicationMRI-Negative Epilepsy
Subtitle of host publicationEvaluation and Surgical Management
PublisherCambridge University Press
Pages237-239
Number of pages3
ISBN (Electronic)9781139525312
ISBN (Print)9781107034235
DOIs
StatePublished - Jan 1 2015

Fingerprint

Malformations of Cortical Development
Pathology
Epilepsy
Partial Epilepsy
Sclerosis
Seizures
Focal cortical dysplasia of Taylor
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ryvlin, P., & So, E. L. (2015). Conclusion. In MRI-Negative Epilepsy: Evaluation and Surgical Management (pp. 237-239). Cambridge University Press. https://doi.org/10.1017/CBO9781139525312.022

Conclusion. / Ryvlin, Philippe; So, Elson L.

MRI-Negative Epilepsy: Evaluation and Surgical Management. Cambridge University Press, 2015. p. 237-239.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ryvlin, P & So, EL 2015, Conclusion. in MRI-Negative Epilepsy: Evaluation and Surgical Management. Cambridge University Press, pp. 237-239. https://doi.org/10.1017/CBO9781139525312.022
Ryvlin P, So EL. Conclusion. In MRI-Negative Epilepsy: Evaluation and Surgical Management. Cambridge University Press. 2015. p. 237-239 https://doi.org/10.1017/CBO9781139525312.022
Ryvlin, Philippe ; So, Elson L. / Conclusion. MRI-Negative Epilepsy: Evaluation and Surgical Management. Cambridge University Press, 2015. pp. 237-239
@inbook{2a5e4260911748779bacb904687a840a,
title = "Conclusion",
abstract = "The 20 chapters in this book offer a comprehensive review of currently available knowledge regarding epilepsy surgery in MRI-negative patients, and they suggest that we have entered a novel era for treating these patients with the most challenging epilepsies. Three primary messages in this book deserve to be emphasized. The first message is that re-evaluation of MRI data, either through optimal acquisition (more sensitive sequence, higher-field strength), post-processing tools, coregistration with other modalities (especially FDG-PET), and expert reassessment, enhances the detection of a large proportion of MRI-negative pathologies, such as focal cortical dysplasias (FCD) (Chapter 3). Up to 89{\%} of small FCD overlooked by experts could be detected by using sophisticated post-processing methods of 3D-T1 MR images, coupled with neural networks automatic detection (Chapter 3). The second message relates to the conceptual framework of presurgical evaluation. In patients with refractory focal epilepsy whose MRI discloses a well-defined epileptogenic lesion, presurgical evaluation concentrates on refining the localization of the epileptogenic zone (EZ) to be resected. In MRI-negative patients, presurgical evaluation also needs to provide insights into the underlying pathology for several reasons: (i) the presence and type of underlying pathology have a strong impact on the chance of postsurgical seizure freedom, with optimal surgical outcome in focal cortical dysplasia (FCD) type II and end- folium sclerosis, and poorest outcome in patients with histologically normal resected tissue; (ii) the extent of the EZ varies with the underlying pathology, being usually circumscribed to a sulcus in MRI-negative FCD type II, and often much more extensive in FCD type I (Chapter 11); and (iii) interpretation of presurgical data, such as the presence or absence of a clear-cut interictal hypometabolism on FDG-PET, will differ as a function of the suspected pathology. In other words, the “what” appears as important as the “where” when contemplating surgical treatment of MRI-negative patients.",
author = "Philippe Ryvlin and So, {Elson L.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1017/CBO9781139525312.022",
language = "English (US)",
isbn = "9781107034235",
pages = "237--239",
booktitle = "MRI-Negative Epilepsy",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Conclusion

AU - Ryvlin, Philippe

AU - So, Elson L.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The 20 chapters in this book offer a comprehensive review of currently available knowledge regarding epilepsy surgery in MRI-negative patients, and they suggest that we have entered a novel era for treating these patients with the most challenging epilepsies. Three primary messages in this book deserve to be emphasized. The first message is that re-evaluation of MRI data, either through optimal acquisition (more sensitive sequence, higher-field strength), post-processing tools, coregistration with other modalities (especially FDG-PET), and expert reassessment, enhances the detection of a large proportion of MRI-negative pathologies, such as focal cortical dysplasias (FCD) (Chapter 3). Up to 89% of small FCD overlooked by experts could be detected by using sophisticated post-processing methods of 3D-T1 MR images, coupled with neural networks automatic detection (Chapter 3). The second message relates to the conceptual framework of presurgical evaluation. In patients with refractory focal epilepsy whose MRI discloses a well-defined epileptogenic lesion, presurgical evaluation concentrates on refining the localization of the epileptogenic zone (EZ) to be resected. In MRI-negative patients, presurgical evaluation also needs to provide insights into the underlying pathology for several reasons: (i) the presence and type of underlying pathology have a strong impact on the chance of postsurgical seizure freedom, with optimal surgical outcome in focal cortical dysplasia (FCD) type II and end- folium sclerosis, and poorest outcome in patients with histologically normal resected tissue; (ii) the extent of the EZ varies with the underlying pathology, being usually circumscribed to a sulcus in MRI-negative FCD type II, and often much more extensive in FCD type I (Chapter 11); and (iii) interpretation of presurgical data, such as the presence or absence of a clear-cut interictal hypometabolism on FDG-PET, will differ as a function of the suspected pathology. In other words, the “what” appears as important as the “where” when contemplating surgical treatment of MRI-negative patients.

AB - The 20 chapters in this book offer a comprehensive review of currently available knowledge regarding epilepsy surgery in MRI-negative patients, and they suggest that we have entered a novel era for treating these patients with the most challenging epilepsies. Three primary messages in this book deserve to be emphasized. The first message is that re-evaluation of MRI data, either through optimal acquisition (more sensitive sequence, higher-field strength), post-processing tools, coregistration with other modalities (especially FDG-PET), and expert reassessment, enhances the detection of a large proportion of MRI-negative pathologies, such as focal cortical dysplasias (FCD) (Chapter 3). Up to 89% of small FCD overlooked by experts could be detected by using sophisticated post-processing methods of 3D-T1 MR images, coupled with neural networks automatic detection (Chapter 3). The second message relates to the conceptual framework of presurgical evaluation. In patients with refractory focal epilepsy whose MRI discloses a well-defined epileptogenic lesion, presurgical evaluation concentrates on refining the localization of the epileptogenic zone (EZ) to be resected. In MRI-negative patients, presurgical evaluation also needs to provide insights into the underlying pathology for several reasons: (i) the presence and type of underlying pathology have a strong impact on the chance of postsurgical seizure freedom, with optimal surgical outcome in focal cortical dysplasia (FCD) type II and end- folium sclerosis, and poorest outcome in patients with histologically normal resected tissue; (ii) the extent of the EZ varies with the underlying pathology, being usually circumscribed to a sulcus in MRI-negative FCD type II, and often much more extensive in FCD type I (Chapter 11); and (iii) interpretation of presurgical data, such as the presence or absence of a clear-cut interictal hypometabolism on FDG-PET, will differ as a function of the suspected pathology. In other words, the “what” appears as important as the “where” when contemplating surgical treatment of MRI-negative patients.

UR - http://www.scopus.com/inward/record.url?scp=84952705365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84952705365&partnerID=8YFLogxK

U2 - 10.1017/CBO9781139525312.022

DO - 10.1017/CBO9781139525312.022

M3 - Chapter

AN - SCOPUS:84952705365

SN - 9781107034235

SP - 237

EP - 239

BT - MRI-Negative Epilepsy

PB - Cambridge University Press

ER -